chr1-17005181-A-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022089.4(ATP13A2):c.289-109T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022089.4 intron
Scores
Clinical Significance
Conservation
Publications
- Kufor-Rakeb syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Illumina
- autosomal recessive spastic paraplegia type 78Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
- parkinsonism due to ATP13A2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022089.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP13A2 | TSL:1 MANE Select | c.289-109T>G | intron | N/A | ENSP00000327214.8 | Q9NQ11-1 | |||
| ATP13A2 | TSL:1 | c.289-109T>G | intron | N/A | ENSP00000413307.1 | Q9NQ11-3 | |||
| ATP13A2 | TSL:1 | c.289-109T>G | intron | N/A | ENSP00000341115.5 | Q9NQ11-2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 22
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at